Elizabeth Murphy Lilly - 29 Dec 2023 Form 4 Insider Report for APOGEE ENTERPRISES, INC. (APOG)

Role: Director
Signature: /s/ Meghan M. Elliott, Attorney-in-Fact for Elizabeth Murphy Lilly
Issuer symbol: APOG
Transactions as of: 29 Dec 2023
Net transactions value: +$427
Form type: 4
Filing time: 03 Jan 2024, 14:45:06 UTC
Previous filing: 03 Oct 2023
Next filing: 01 Apr 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APOG	Deferred Restricted Stock Units	Award	$427	+8	+0.44%	$53.41	1,824	29 Dec 2023	Common Stock	8	$0.000000	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.
F2	Settled 1-for-1.
F3	Additional deferred restricted stock units were allocated pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.